JUL 19, 2020 6:55 PM PDT

Nanodrug for Treating Invasive Breast Cancer

WRITTEN BY: Nouran Amin

Scientists at the University of Arkansas created a nano-drug that may eradicate triple-negative breast cancer cells.

Findings were published in Advanced Therapeutics.

"With the exception of skin cancers, breast cancer is the most common form of cancer in American women," said Hassan Beyzavi, assistant professor in the Department of Chemistry and Biochemistry. "As we know, thousands of women die from breast cancer each year. Patients with triple negative cells are especially vulnerable, because of the toxic side effects of the only approved treatment for this type of cancer. We've addressed this problem by developing a co-formulation that targets cancer cells and has no effect on healthy cells."

Learn more about triple negative breast cancer:

Triple negative breast cancer is an aggressive cancer type characterized by a lack estrogen receptors, progesterone receptors and human epidermal growth factor receptor 2. As a result, the cancer can not be treated with receptor-targeted therapy. To make matters worse, the cancer is often challenging to treat with existing chemotherapy and often needs invasive surgery.

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 18, 2020
Cancer
Could Targeting the Proteasome be Effective Against Cancer?
NOV 18, 2020
Could Targeting the Proteasome be Effective Against Cancer?
One of the trickiest things about anti-cancer drug design is targeting. Today, most drugs on the market target critical ...
NOV 17, 2020
Drug Discovery & Development
Antibiotics Before Age 2 Linked to Childhood Health Conditions
NOV 17, 2020
Antibiotics Before Age 2 Linked to Childhood Health Conditions
Researchers from Mayo Clinic have found a link between children aged two and under taking antibiotics and an increased r ...
NOV 23, 2020
Drug Discovery & Development
Therapeutically Active Ion-Channels
NOV 23, 2020
Therapeutically Active Ion-Channels
Therapeutically relevant ion channels have inspired researchers to look into drugs that can regulate their activity. Ion ...
DEC 08, 2020
Immunology
Drug Targets Cold Tumors' Achilles Heel
DEC 08, 2020
Drug Targets Cold Tumors' Achilles Heel
Immunotherapies have emerged as a powerful treatment modality for cancer. They join chemotherapy, surgery, radiotherapy, ...
DEC 25, 2020
Drug Discovery & Development
Why Some Cancer Cells Are Drug Resistant?
DEC 25, 2020
Why Some Cancer Cells Are Drug Resistant?
Cancer is one of the most prominent diseases in the world. It takes many lives every year and treatment likely faces dru ...
DEC 25, 2020
Drug Discovery & Development
Class of Antibiotics May Target Resistant Bacteria
DEC 25, 2020
Class of Antibiotics May Target Resistant Bacteria
Researchers found a new class of antibiotics for combatting antimicrobial resistance (AMR). Learn more about antibiotic ...
Loading Comments...